PPS&V Asset Management Consultants’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
PPS&V Asset Management Consultants's BMY Position: Q2 2026 in Review
PPS&V Asset Management Consultants sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,837 shares — an estimated $293K sold.
PPS&V Asset Management Consultants first reported a position in BMY in Q3 2024 and held it in 7 quarters. The position peaked at $349K in Q1 2025. 721 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- PPS&V Asset Management Consultants reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- PPS&V Asset Management Consultants sold 4,837 Bristol-Myers Squibb shares in Q2 2026, an estimated $293K.
- PPS&V Asset Management Consultants first reported a position in Bristol-Myers Squibb in Q3 2024 and held it in 7 quarters.
- PPS&V Asset Management Consultants's Bristol-Myers Squibb position peaked at $349K in Q1 2025.
- 721 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on PPS&V Asset Management Consultants's 13F filing for Q2 2026, filed 6 Jul 2026.